SCHEMBL24844836

SCHEMBL24844836

C1CCCC(c2noc(C3CCNCC3)n2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP7 Q93009 1/20 0.47
CNR1 P21554 1/20 0.44
CNR2 P34972 1/20 0.44
GRM5 P41594 1/20 0.44
PLAT P00750 3/20 0.44
CASP3 P42574 2/20 0.44
SENP7 Q9BQF6 2/20 0.44
SENP6 Q9GZR1 2/20 0.44
POLB P06746 1/20 0.44
NR1H4 Q96RI1 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HRH4 Q9H3N8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12506163 1.00 USP7 (0.47) USP7CNR1CNR2GRM5PLAT
SCHEMBL12505958 0.98 USP7 (0.48) USP7CNR1CNR2GRM5PLAT
SCHEMBL12070540 0.95 USP7 (0.48) USP7CNR1CNR2GRM5PLAT
SCHEMBL12069893 0.91 USP7 (0.50) USP7CNR1CNR2GRM5PLAT
SCHEMBL12070397 0.91 USP7 (0.50) USP7CNR1CNR2GRM5PLAT
SCHEMBL23624594 0.89 CASP3 (0.51) CNR1CNR2GRM5CASP3SENP7
SCHEMBL12255466 0.81 NR1H4 (0.41) USP7GRM5PLATNR1H4
SCHEMBL3127019 0.81 CNR1 (0.48) CNR1CNR2GRM5CASP3SENP7
SCHEMBL15508611 0.81 GRM5 (0.41) CNR1CNR2GRM5PLATCASP3
Hydrochloric Acid SCHEMBL4229174 0.80 GRM5 (0.40) CNR1CNR2GRM5CASP3SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023275744-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS TECNIMEDE - Sociedade Técnico-medicinal, SA (PT) 2023-01-05 WO disclosed